Updated Jul 16, 2026 · Last SEC filing 2026-07-01
PRECIGEN, INC. (PGEN) has filed 18 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 2 Form 8-K material event filings were reported by PGEN in the last 90 days. 4 Form 144 notices of proposed sale were filed for PGEN stock. InsiderAlpha tracks every PGEN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001356090 |
| Form 4 filings (90d) | 18 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Thomasian Harry Jr. | Chief Financial Officer | S — Open-market sale | 171.4K | $5.53 | $948K | SEC | |
| Sabzevari Helen | President and CEO | M — Option exercise | 346.8K | $2.33 | $808K | SEC | |
| Sabzevari Helen | President and CEO | S — Open-market sale | 346.8K | $5.89 | $2.04M | SEC | |
| Shah Rutul R | Chief Operating Officer | S — Open-market sale | 42.9K | $5.85 | $251K | SEC | |
| Thomasian Harry Jr. | Chief Financial Officer | S — Open-market sale | 28.6K | $5.78 | $165K | SEC | |
| Shah Rutul R | Chief Operating Officer | M — Option exercise | 42.9K | $2.33 | $100K | SEC | |
| Thomasian Harry Jr. | Chief Financial Officer | S — Open-market sale | 41.9K | $4.36 | $183K | SEC | |
| Sabzevari Helen | President and CEO | S — Open-market sale | 119.2K | $4.36 | $520K | SEC | |
| Tennant Phil | Chief Commercial Officer | S — Open-market sale | 30.3K | $4.36 | $132K | SEC | |
| Shah Rutul R | Chief Operating Officer | S — Open-market sale | 42.7K | $4.36 | $186K | SEC | |
| Lehr Donald P. | Chief Legal Officer | S — Open-market sale | 29.1K | $4.36 | $127K | SEC | |
| Shah Rutul R | Chief Operating Officer | M — Option exercise | 90.0K | — | — | SEC | |
| Lehr Donald P. | Chief Legal Officer | M — Option exercise | 62.5K | — | — | SEC | |
| Tennant Phil | Chief Commercial Officer | M — Option exercise | 62.5K | — | — | SEC | |
| Sabzevari Helen | President and CEO | M — Option exercise | 250.0K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for PRECIGEN, INC. (PGEN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Shah Rutul R | 8 | $537K |
| Sabzevari Helen | 8 | $3.37M |
| Thomasian Harry Jr. | 7 | $1.30M |
| Tennant Phil | 5 | $132K |
| Lehr Donald P. | 5 | $127K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PGEN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PGEN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.